Continuing chemotherapy and immunotherapy treatment in cancer patients with Covid-19 is not a risk to their survival, a study suggests. It also recommends further research into the drug hydroxychloroquine, which appeared to benefit some patients. The findings, from 890 infected cancer patients in the UK, Spain, Italy and Germany, could help identify who is most… Read More: Chemotherapy in cancer patients with Covid-19 ‘not a risk’ »
There may be new trouble ahead for states that had gotten COVID-19 under control after the March and April surges but are now seeing case numbers drift up. The movement may be an early signal that governors and other local officials need to take modest steps to head off the need for more drastic measures… Read More: Is it time to resume COVID restrictions in some safe… »
People from ethnic minority backgrounds in Britain “face greater barriers” when trying to protect themselves from coronavirus, according to a report. The Runnymede Trust, a race equality think-tank, said Bangladeshi and black African people were most vulnerable. Jobs, households and using public transport are all said to be risk factors. The government said it is… Read More: Coronavirus: Ethnic minorities ‘over-exposed’ to Covid-19 »
Signage is displayed on the exterior of the Humana Inc. office building in Louisville, Kentucky, … [+] U.S., on Saturday, Nov. 26, 2016. . Photographer: Luke Sharrett/Bloomberg © 2016 Bloomberg Finance LP Humana profits doubled to $ 1.8 billion in the second quarter as elective procedures the large health insurer pays for were postponed or… Read More: Humana Profits Double As Seniors Defer Care In Covid-19 Pandemic »